Related references
Note: Only part of the references are listed.Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomnia
Gunjan Junnarkar et al.
EXPERT OPINION ON DRUG DISCOVERY (2022)
Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments
Luke A. McGuinness et al.
RESEARCH SYNTHESIS METHODS (2021)
Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy
Richard K. Bogan et al.
SLEEP (2021)
Pitolisant versus placebo for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: A meta-analysis from randomized controlled trials
Jiahe Wang et al.
PHARMACOLOGICAL RESEARCH (2021)
Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment
Kiran Maski et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2021)
European guideline and expert statements on the management of narcolepsy in adults and children
Claudio L. A. Bassetti et al.
EUROPEAN JOURNAL OF NEUROLOGY (2021)
Health-related quality of life in narcolepsy: A systematic review and meta-analysis
Ragy Tadrous et al.
JOURNAL OF SLEEP RESEARCH (2021)
Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea
Atul Malhotra et al.
SLEEP (2020)
Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy
Helene A. Emsellem et al.
SLEEP MEDICINE (2020)
Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial
Yves Dauvilliers et al.
CNS DRUGS (2020)
Efficacy and safety of solriamfetol for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a systematic review and meta-analysis of clinical trials
Roshan Subedi et al.
SLEEP MEDICINE (2020)
A randomized study of solriamfetol for excessive sleepiness in narcolepsy
Michael J. Thorpy et al.
ANNALS OF NEUROLOGY (2019)
Gamma-hydroxybutyrate (GHB) for narcolepsy in adults: an updated systematic review and meta-analysis
Xiao-Min Xu et al.
SLEEP MEDICINE (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Multiple treatment comparison in narcolepsy: a network meta-analysis
Philippe Lehert et al.
SLEEP (2018)
Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial
Zoltan Szakacs et al.
LANCET NEUROLOGY (2017)
Safety and efficacy of long-term use of sodium oxybate for narcolepsy with cataplexy in routine clinical practice
Panagis Drakatos et al.
SLEEP MEDICINE (2017)
The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use
Marta Kollb-Sielecka et al.
SLEEP MEDICINE (2017)
Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study
Chad Ruoff et al.
SLEEP (2016)
Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study
Chad Ruoff et al.
SLEEP (2016)
Ranking treatments in frequentist network meta-analysis works without resampling methods
Gerta Ruecker et al.
BMC MEDICAL RESEARCH METHODOLOGY (2015)
Narcolepsy
Thomas E. Scammell
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy
Richard K. Bogan et al.
SLEEP MEDICINE (2015)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
International Classification of Sleep Disorders-Third Edition Highlights and Modifications
Michael J. Sateia
CHEST (2014)
A graphical tool for locating inconsistency in network meta-analyses
Ulrike Krahn et al.
BMC MEDICAL RESEARCH METHODOLOGY (2013)
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial
Yves Dauvilliers et al.
LANCET NEUROLOGY (2013)
Checking consistency in mixed treatment comparison meta-analysis
S. Dias et al.
STATISTICS IN MEDICINE (2010)
Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain Clinical Implications
Nora D. Volkow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Modafinil improves information processing speed and increases energetic resources for orientation of attention in narcoleptics: Double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA)
Michael Saletu et al.
SLEEP MEDICINE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Sodium oxybate improves excessive daytime sleepiness in narcolepsy
Jed Black et al.
SLEEP (2006)
The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy
John R. Harsh et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients
SLEEP MEDICINE (2005)
Meta-analyses involving cross-over trials: methodological issues
DR Elbourne et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2002)
Dopaminergic role in stimulant-induced wakefulness
JP Wisor et al.
JOURNAL OF NEUROSCIENCE (2001)
A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy
H. Moldofsky et al.
SLEEP MEDICINE (2000)
Share Paper
